Form 4: EKSO CFO Sells Shares for Tax Obligations

EKSO Bionics CFO Jerome Wong sold 11,288 shares of common stock at $4.7990 per share to cover tax withholding obligations related to restricted stock awards.

Summary

• Jerome Wong, Chief Financial Officer of EKSO Bionics Holdings, Inc., reported a sale of common stock.
• The transaction involved 11,288 shares sold on November 10, 2025.
• The shares were sold at a price of $4.7990 per share.
• The purpose of the sale was to cover tax withholding obligations incurred upon the vesting and settlement of restricted stock awards.
• Following the transaction, Mr. Wong directly beneficially owns 26,009 shares of common stock.
• Additionally, Mr. Wong indirectly beneficially owns 2,876 shares through a 401(k) plan.
• All reported amounts reflect a 1-for-15 reverse stock split effected by the Issuer on June 2, 2025.

Sentiment

Score: 5

Explanation: The transaction is a routine insider sale to cover tax obligations from restricted stock vesting, which is a neutral event for company operations, though it slightly reduces insider ownership.

Positives

• The underlying vesting and settlement of restricted stock awards indicate compensation realization for the CFO.

Negatives

• An insider sale, even for tax purposes, reduces the executive's direct equity stake in the company.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

This filing reports a routine insider transaction for tax purposes and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but the sale is for a routine tax obligation rather than a discretionary divestment.

Key Dates

Keywords

EKSO Bionics, Jerome Wong, CFO, Insider Trading, Form 4, Stock Sale, Restricted Stock Awards, Tax Obligations, Reverse Stock Split